Variant · Snv
IFI27L1 NM_206949.3(IFI27L1):c.61+1G>A
CI-VAR-00294818Explore in graph →NM_206949.3:c.61+1G>AClinVar 2428766 rs144379529
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 2428766 | Likely risk allele | no assertion criteria provided | 0 | Susceptibility to severe COVID-19; Sarcoma; Ovarian serous cystadenocarcinoma; Thymoma; Adrenocortical carcinoma, hereditary; Lung cancer; Familial cancer of breast | germline | 2 | Jul 01, 2022 | clinvar |